[{"Assets_0_Q2_USD":128076000000.0,"CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q2_USD":0.45,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.45,"Country":"United States","EarningsPerShareBasic_1_Q2_USD":-0.04,"EarningsPerShareBasic_2_Q2_USD":-0.38,"EarningsPerShareDiluted_1_Q2_USD":-0.04,"EarningsPerShareDiluted_2_Q2_USD":-0.38,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162365000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":8163000000.0,"NetIncomeLossConverted_1_Q2_USD":-85000000.0,"NetIncomeLossConverted_2_Q2_USD":-860000000.0,"OfficialName":"Bristol-Myers Squibb Company Common Stock","RevenuesConverted_1_Q2_USD":10129000000.0,"RevenuesConverted_2_Q2_USD":20910000000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":49160000000.0,"StockholdersEquity_0_Q2_USD":49094000000.0,"Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":2263000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":2261000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":2263000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":2261000000.0,"filed":"20200806","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2020.0","name":"BRISTOL MYERS SQUIBB CO","period":"20200630","qtrs":"2","uom":"USD"}]